elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26796309-02939F42-76FD-4C07-9113-D6A0D78A698B
Q26796309-02939F42-76FD-4C07-9113-D6A0D78A698B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26796309-02939F42-76FD-4C07-9113-D6A0D78A698B
Immune Effects of Chemotherapy, Radiation, and Targeted Therapy and Opportunities for Combination With Immunotherapy
P2860
Q26796309-02939F42-76FD-4C07-9113-D6A0D78A698B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26796309-02939F42-76FD-4C07-9113-D6A0D78A698B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
515cd204ad2ec67d9ff5c860c64f91e898c7425c
P2860
Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study.